Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · IEX Real-Time Price · USD
62.07
+1.53 (2.53%)
At close: May 3, 2024, 4:00 PM
62.58
+0.51 (0.82%)
After-hours: May 3, 2024, 6:22 PM EDT
Exact Sciences Employees
Exact Sciences had 6,600 employees on December 31, 2023. The number of employees increased by 200 or 3.13% compared to the previous year.
Employees
6,600
Change (1Y)
200
Growth (1Y)
3.13%
Revenue / Employee
$378,752
Profits / Employee
-$30,932
Market Cap
11.41B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6,600 | 200 | 3.13% |
Dec 31, 2022 | 6,400 | -100 | -1.54% |
Dec 31, 2021 | 6,500 | 1,500 | 30.00% |
Dec 31, 2020 | 5,000 | 890 | 21.65% |
Dec 31, 2019 | 4,110 | 2,133 | 107.89% |
Dec 31, 2018 | 1,977 | 709 | 55.91% |
Dec 31, 2017 | 1,268 | 532 | 72.28% |
Dec 31, 2016 | 736 | 59 | 8.71% |
Dec 31, 2015 | 677 | 441 | 186.86% |
Dec 31, 2014 | 236 | 134 | 131.37% |
Dec 31, 2013 | 102 | 15 | 17.24% |
Dec 31, 2012 | 87 | 26 | 42.62% |
Dec 31, 2011 | 61 | 26 | 74.29% |
Dec 31, 2010 | 35 | 16 | 84.21% |
Dec 31, 2009 | 19 | 15 | 375.00% |
Dec 31, 2008 | 4 | -10 | -71.43% |
Dec 31, 2007 | 14 | -8 | -36.36% |
Dec 31, 2006 | 22 | -27 | -55.10% |
Dec 31, 2005 | 49 | -22 | -30.99% |
Dec 31, 2004 | 71 | -11 | -13.41% |
Dec 31, 2003 | 82 | 7 | 9.33% |
Dec 31, 2002 | 75 | 7 | 10.29% |
Dec 31, 2001 | 68 | 24 | 54.55% |
Dec 31, 2000 | 44 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Tenet Healthcare | 106,500 |
Universal Health Services | 96,700 |
DaVita | 70,000 |
Charles River Laboratories International | 21,800 |
Smith & Nephew | 19,081 |
Catalent | 17,800 |
AptarGroup | 13,800 |
Natera | 3,293 |
EXAS News
- 4 days ago - Exact Sciences to Participate in May Investor Conference - Business Wire
- 20 days ago - Exact Sciences Names Aaron Bloomer as New Chief Financial Officer - Business Wire
- 24 days ago - Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes - Business Wire
- 27 days ago - Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024 - Business Wire
- 27 days ago - Exact Sciences Schedules First Quarter 2024 Earnings Call - Business Wire
- 4 weeks ago - Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment - Business Wire
- 5 weeks ago - Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer - Business Wire
- 5 weeks ago - Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner - Business Wire